LLC [LL/2; LLC1]（小鼠肺癌细胞）

Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model(2024)

作者：Chenxu Shao, Xiaoping Yan, Shangjie Pang, Di Nian, Li Ren, Hui Li, Junjie Sun

期刊：INTERNATIONAL IMMUNOPHARMACOLOGY

DOI：10.1016/j.intimp.2024.111781

影响因子：5.6

引用产品： LLC [LL/2; LLC1] 细胞, 特级胎牛血清

Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer(2024)

作者：Cuijiao Feng, Na Li, Guangqi Gao, Qiuwen He, Lai-Yu Kwok, Heping Zhang

期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

DOI：10.3390/ijms25073768

影响因子：5.6

引用产品： LLC [LL/2; LLC1] 细胞, DMEM/F12 培养基

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung Adenocarcinoma with EGFR19Del(2024)

作者：Yao Li, Yaping Long, Xiangwei Ge, Pengfei Zhang, Tao Li, Liangliang Wu, Hao Fan, Zhijuan Du, Qiaowei Liu, Yi Hu

期刊：Vaccines

DOI：10.3390/vaccines12121412

影响因子：5.2

引用产品： LLC [LL/2; LLC1] 细胞

A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer(2024)

作者：Yueyang Zhang, Ying Chen, Bo Wang, Ying Cai, Menghang Zhang, Xin Guo, Aobo Wu, Weidong Wang, Na Liu, Xianping Wang, Yongsheng Gong, Jicheng Pan, Yanxia Jin

期刊：BIOORGANIC CHEMISTRY

DOI：10.1016/j.bioorg.2024.107459

影响因子：5.1

引用产品： A549 [A-549] 细胞, LLC [LL/2; LLC1] 细胞, NCI-H1437 细胞, NCI-H157 细胞

Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor(2024)

作者：Wang Mengjiao, Wan Quan, Wang Chenglv, Jing Qianyu, Nie Yujie, Zhang Xiangyan, Chen Xin, Yang De, Pan Runsang, Li Linzhao, Zhu Lan, Gui Huan, Chen Shuanghui, Deng Yuezhen, Chen Tao, Nie Yingjie

期刊：MOLECULAR AND CELLULAR BIOCHEMISTRY

DOI：10.1007/s11010-024-04966-6

影响因子：4.3

引用产品： 4T1 细胞, LLC [LL/2; LLC1] 细胞

Cremastrae Pseudobulbus Pleiones Pseudobulbus (CPPP) Against Non-Small-Cell Lung Cancer: Elucidating Effective Ingredients and Mechanism of Action(2024)

作者：Yuxin Cao, Zhuangzhuang Hao, Mengmeng Liu, Jingwen Xue, Yuqing Wang, Yu Wang, Jiayuan Li, Yifan Lu, Chunguo Wang, Jinli Shi

期刊：Pharmaceuticals

DOI：10.3390/ph17111515

影响因子：4.3

引用产品： LLC [LL/2; LLC1] 细胞

Candida albicans-Derived β-Glucan as a Novel Modulator of Tumor Microenvironment: Targeting Macrophage Polarization and Inducing Ferroptosis in Lung Cancer(2024)

作者：Xiang He, Qin Ran, Xiaolan Li, Anying Xiong, Lei Zhang, Manling Jiang, Lingling Bai, Dan Peng, Junyi Wang, Baoqing Sun, Guoping Li

期刊：Journal of Inflammation Research

DOI：10.2147/JIR.S489191

影响因子：4.2

引用产品： LLC [LL/2; LLC1] 细胞, B16 细胞

HDAC3 inhibitors induce drug resistance by promoting IL-17 A production by T cells(2024)

作者：Chen Hao, Qin Anqi, Xu Fan, Guo Shuai, Zhang Ge, Zhang Aihong, Li WenTing, Tian Feng, Zheng Quanhui

期刊：Scientific Reports

DOI：10.1038/s41598-024-83447-8

影响因子：3.8

引用产品： LLC [LL/2; LLC1] 细胞, EL4 细胞, 特级胎牛血清

Gut microbiome affects the response to immunotherapy in non-small cell lung cancer(2024)

作者：Shengnan Ren, Lingxin Feng, Haoran Liu, Yuke Mao, Zhuang Yu

期刊：Thoracic Cancer

DOI：10.1111/1759-7714.15303

影响因子：2.9

引用产品： LLC [LL/2; LLC1] 细胞

The effect and mechanism of IL-37d on neutrophil recruitment in the early stage of tumor metastasis in the lungs(2024)

作者：Guan Yetong, Gao Chang, Guo Yan, Wang Meifang, Zhang Lining

期刊：Discover Oncology

DOI：10.1007/s12672-024-01608-7

影响因子：2.8

引用产品： LLC [LL/2; LLC1] 细胞